About Kineta, Inc. 
Kineta, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 4 Schemes (2.88%)
Foreign Institutions
Held by 7 Foreign Institutions (0.59%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
(Quarterly Results - Mar 2025)
Net Profit:
-2 Million
Pharmaceuticals & Biotechnology
USD 5 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-0.11
62.88%
-0.34






